CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MRUS is no longer listed: the SEC shows no trading symbol for it and it has no recent price, usually after an acquisition. CatalystAlert no longer tracks its catalysts.

Merus N.V.

MRUS
$6.83BMid Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for MRUS. That does not mean none is planned.

Get an email about MRUS's next catalysts

Track Merus (MRUS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth America3584 CM UTRECHT260 employees
Drug Pipeline

Frequently asked questions

What is in Merus N.V.'s drug pipeline?β†’

CatalystAlert tracks 4 drug candidates in Merus N.V.'s (MRUS) pipeline across Phase 3, Phase 2. Its lead program is Petosemtamab (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Merus N.V.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Merus N.V. (MRUS) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track MRUS biotech catalysts?β†’

Add MRUS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Merus N.V.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply